Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-01FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for SELARSDI (USTEKINUMAB-AEKN), a biosimilar to ustekinumab.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 pediatric trial evaluating ustekinumab for moderately to severely active Crohn's disease has been completed. The study was conduct…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. [Phase 4]
A Phase 4 clinical trial comparing vedolizumab versus dose-intensive adalimumab in Crohn's disease patients who have lost response or show b…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
This entry announces an ongoing clinical trial using ultrasound and proteomics to assess responses to guselkumab in Crohn's disease.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-11-21EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG
The European Medicines Agency authorised Usgena, a ustekinumab product from STADA, for treatment of Crohn's disease, psoriasis, psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants [Phase 1]
A Phase 1 multiple ascending dose study of AGMB-129 in healthy participants has completed.
-
EMA approval · 2025-11-21EMA Authorised: Pyzchiva (ustekinumab) — Samsung Bioepis NL B.V.
EMA authorised Pyzchiva (ustekinumab) for Crohn's disease, ulcerative colitis, and psoriatic arthritis.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease [Phase 2]
A Phase 2 clinical trial (NCT05843578) is evaluating AGMB-129 for safety, tolerability, pharmacokinetics and pharmacodynamics in patients wi…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of the SMART IBD App in Pediatric IBD [NA]
A pediatric inflammatory bowel disease trial evaluating the SMART IBD app is currently recruiting to assess its use in managing IBD symptoms…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients. [NA]
Clinical trial sponsored by Hospices Civils de Lyon is recruiting to evaluate sleep changes in patients with inflammatory bowel diseases. Th…
-
FDA approval · 2025-11-20FDA Approved: IMULDOSA — Supplemental Application (Accord BioPharma Inc.)
FDA approved a supplemental application for IMULDOSA (USTEKINUMAB-SRLF) from Accord BioPharma Inc. The action updates the regulatory status …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Cranberry and Gut Health in Crohn's Disease [EARLY_Phase 1]
An early-phase 1 clinical trial is investigating cranberry's effect on gut health in people with Crohn's disease. The study is currently rec…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Behavioral Therapy for Crohn's Disease [NA]
A clinical trial sponsored by Icahn School of Medicine at Mount Sinai is evaluating behavioral therapy for Crohn's disease and is currently …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
A clinical trial update describing a study to optimize inflammatory bowel disease treatment by understanding gut virome heterogeneity, curre…
-
FDA approval · 2025-11-19FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SELARSDI (ustekinumab-aeKn) from Teva Pharmaceuticals USA, Inc. The product is a ustekinumab bio…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease [NA]
This clinical trial update describes a study evaluating diffusion-weighted MR-enterography, with or without bowel cleansing, to assess infla…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
A pediatric inflammatory bowel disease trial to assess and educate patients and families on reducing ultra-processed food consumption.
-
FDA approval · 2025-11-18FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery [NA]
This completed clinical study from Weill Medical College of Cornell University analyzes biologic signatures in Crohn's disease patients unde…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion [NA]
Clinical trial update describing a study on education for patients requiring a digestive stoma for fecal diversion, applicable to several co…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
Clinical trial update reporting completion of a study evaluating subcutaneous adalimumab (Humira) in adults with moderate to severe Crohn's …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Survey of Darvadstrocel in People With Crohn's Disease
Takeda is conducting a trial to evaluate darvadstrocel (Alofisel) in people with Crohn's disease, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Laparoscopic Right Hemicolectomy for Crohn's Disease of the Terminal Ileum Utilizing the Mesenteric Excision and Exclusion
A clinical trial update indicates a laparoscopic right hemicolectomy for Crohn's disease of the terminal ileum using mesenteric excision and…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: A Study of Vedolizumab in Adults With Crohn's Disease (CD)
A completed clinical trial evaluating Vedolizumab in adults with Crohn's disease has finished (NCT05192863). The study was sponsored by Take…